Reliance GeneMedix (GMX)

 1.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 2.25
  • 52 Week Low: 1.00
  • Currency: UK Pounds
  • Shares Issued: 190.49m
  • Volume: 0
  • Market Cap: £2.86m
  • RiskGrade: 420
  • Beta: 0.26

Latest ShareCast News

Reliance GeneMedix falls further into the red

Date: Thursday 01 Sep 2011

Biopharmaceutical firm Reliance GeneMedix widened its losses in the year to the end of March.

GMX Regulatory News

2011 Interim Results 16-Dec-2011 07:00 RNS
Result of AGM 28-Sep-2011 07:00 RNS
Final Results 01-Sep-2011 07:00 RNS
Related Party Transaction 19-Jul-2011 08:30 RNS
Update re EPO 30-Mar-2011 07:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GMX Market Data

Currency UK Pounds
Share Price 1.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 2.25
52 Week Low 1.00
Volume 0
Shares Issued 190.49m
Market Cap £2.86m
Beta 0.26
RiskGrade 420

GMX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
69.63% below the market average69.63% below the market average69.63% below the market average69.63% below the market average69.63% below the market average
64.29% below the sector average64.29% below the sector average64.29% below the sector average64.29% below the sector average64.29% below the sector average
Income Not Available
Growth
9.32% above the market average9.32% above the market average9.32% above the market average9.32% above the market average9.32% above the market average
2.04% above the sector average2.04% above the sector average2.04% above the sector average2.04% above the sector average2.04% above the sector average

GMX Dividends

No dividends found

Trades for --2012

Time Volume / Share Price
0 @ 0.000p

GMX Key Personnel

CEO Vinay Ranade

Top of Page